)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Miris
Miris (MIR) investor relations material
Miris Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary28 Aug, 2026
Executive summary
Net sales for Q2 2026 increased by 3% year-over-year to 5,185 tkr, but H1 sales declined 10% due to weak Q1 instrument sales.
Recurring revenues grew 53% in Q2 and 19% in H1, strengthening the revenue base.
Order pipeline expanded by 17% during Q2, indicating rising market interest.
Notable new and repeat orders from the US, Germany, New Zealand, Sweden, and Denmark.
A successful FDA inspection post-period further validated quality processes.
Financial highlights
Q2 2026 net sales: 5,185 tkr (5,015 tkr in Q2 2025); H1 2026 net sales: 8,621 tkr (9,600 tkr in H1 2025).
Q2 2026 net loss after tax: -1,796 tkr (-969 tkr in Q2 2025); H1 2026 net loss: -4,275 tkr (-2,894 tkr in H1 2025).
Q2 EPS: -1.348 kr (-0.006 kr in Q2 2025); H1 EPS: -3.208 kr (-0.019 kr in H1 2025).
Cash at June 30: 443 tkr (587 tkr prior year); net debt/equity ratio: 0.17 (down from -21.46).
Equity at June 30: 15,823 tkr (-502 tkr prior year); solidity improved to 58% from -2%.
Outlook and guidance
Market activity and customer engagement increased in Q2, with expectations of continued stabilization.
Management does not expect to achieve previously stated profitability target for 2026.
Liquidity is projected to be sufficient for at least 12 months, assuming postponement of major development projects.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Miris
- Q1 2026 sales dropped 25% year-over-year, but a robust order pipeline signals recovery ahead.MIR
Q1 2026 - Improved annual results and strong recurring revenue growth, with a solid financial position.MIRQ4 2025
- Revenue up 6.4% and net loss narrowed 37% in Q3, with strong liquidity and global demand.MIRQ3 2025
- Sales up 21% in H1 2025, losses halved, and liquidity boosted by new capital raises.MIRQ2 2025
- First-ever positive monthly result and strong recurring revenue growth mark Miris' Q3 2024.MIRQ3 2024
- Q2 sales rose 32% and net loss halved as Miris expanded globally and strengthened its finances.MIRQ2 2024
- Q1 sales up 28% and net loss narrows as Miris secures funding for growth toward 2026 profitability.MIRQ1 2025
- Revenue up 14% and net loss halved; Miris nears profitability but needs new capital.MIRQ4 2024
Next Miris earnings date
Q3 202627 Nov, 2026
Miris
Next Miris earnings date
Q3 202627 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Miris Holding specializes in developing and providing analytical solutions for the healthcare and food industries. The company focuses on the production of instruments designed to analyze milk composition, supporting applications such as human milk fortification in neonatal care and quality control in the dairy sector. The company is headquartered in Uppsala, Sweden, and its shares are listed on the Nasdaq Stockholm.